Skip to Content
MilliporeSigma
  • Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.

Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.

Journal of virology (2015-05-15)
Leonardo M Cortez, Jody Campeau, Grant Norman, Marian Kalayil, Jacques Van der Merwe, Debbie McKenzie, Valerie L Sim
ABSTRACT

Prion diseases are fatal neurodegenerative disorders associated with the conversion of cellular prion protein (PrPC) into its aberrant infectious form (PrPSc). There is no treatment available for these diseases. The bile acids tauroursodeoxycholic acid(TUDCA) and ursodeoxycholic acid (UDCA) have been recently shown to be neuroprotective in other protein misfolding disease models, including Parkinson’s, Huntington’s and Alzheimer’s diseases, and also in humans with amyotrophic lateral sclerosis.Here, we studied the therapeutic efficacy of these compounds in prion disease. We demonstrated that TUDCA and UDCA substantially reduced PrP conversion in cell-free aggregation assays, as well as in chronically and acutely infected cell cultures. This effect was mediated through reduction of PrPSc seeding ability, rather than an effect on PrPC. We also demonstrated the ability of TUDCA and UDCA to reduce neuronal loss in prion-infected cerebellar slice cultures. UDCA treatment reduced astrocytosis and prolonged survival in RML prion-infected mice. Interestingly, these effects were limited to the males, implying a gender-specific difference in drug metabolism. Beyond effects on PrPSc, we found that levels of phosphorylated eIF2 were increased at early time points, with correlated reductions in postsynaptic density protein 95. As demonstrated for other neurodegenerative diseases, we now show that TUDCA and UDCA may have a therapeutic role in prion diseases, with effects on both prion conversion and neuroprotection. Our findings, together with the fact that these natural compounds are orally bioavailable, permeable to the blood-brain barrier, and U.S. Food and Drug Administration-approved for use in humans, make these compounds promising alternatives for the treatment of prion diseases. Prion diseases are fatal neurodegenerative diseases that are transmissible to humans and other mammals. There are no disease-modifying therapies available, despite decades of research. Treatment targets have included inhibition of protein accumulation,clearance of toxic aggregates, and prevention of downstream neurodegeneration. No one target may be sufficient; rather, compounds which have a multimodal mechanism, acting on different targets, would be ideal. TUDCA and UDCA are bile acids that may fulfill this dual role. Previous studies have demonstrated their neuroprotective effects in several neurodegenerative disease models, and we now demonstrate that this effect occurs in prion disease, with an added mechanistic target of upstream prion seeding. Importantly, these are natural compounds which are orally bioavailable, permeable to the blood-brain barrier, and U.S.Food and Drug Administration-approved for use in humans with primary biliary cirrhosis. They have recently been proven efficacious in human amyotrophic lateral sclerosis. Therefore, these compounds are promising options for the treatment of prion diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Urea-12C, 99.9 atom % 12C
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
BIS-TRIS, BioXtra, ≥98.0% (titration)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
BIS-TRIS, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
BIS-TRIS, ≥98.0% (titration)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea solution, 40 % (w/v) in H2O
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea solution, BioUltra, ~8 M in H2O
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
BIS-TRIS, BioUltra, ≥99.0% (NT)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Glycerol solution, 83.5-89.5% (T)
SKU
Pack Size
Availability
Price
Quantity
SAFC
BIS-TRIS
SKU
Pack Size
Availability
Price
Quantity
SAFC
BIS-TRIS
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, 92.5-100.5% based on total alkyl sulfate content basis
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, ≥90% ((Assay))
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, ReagentPlus®, ≥98.5% (GC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, BioXtra, ≥99.0% (GC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, ACS reagent, ≥99.0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, ≥99.0% (GC), dust-free pellets
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, BioUltra, for molecular biology, ≥99.0% (GC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, ≥98.0% (GC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, ≥99.0%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, SAJ special grade, ≥97.0%
SKU
Pack Size
Availability
Price
Quantity
Supelco
Sodium dodecyl sulfate, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Sodium dodecyl sulfate, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC), free-flowing, Redi-Dri
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea, ACS reagent, 99.0-100.5%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea, powder, BioReagent, for molecular biology, suitable for cell culture
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea, ReagentPlus®, ≥99.5%, pellets
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea, suitable for electrophoresis
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Urea, meets USP testing specifications
SKU
Pack Size
Availability
Price
Quantity